Search results

Found 150 pages
AUTHOR: PharmaTimes Reporter

Results per page

10 20 50 100

Sort by

Relevance Date

24 Mar 2017:

NHS speeds up publication of hospital episode data

The NHS has refined its processes for publishing Hospital Episode Statistics (HES), making the latest dataset available more than a month earlier. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/nhs_speeds_up_publication_of_hospital_episode_data_1189979

14 Aug 2013:

Swiss OK for Takeda's schizophrenia drug lurasidone

Takeda has been granted approval in Switzerland for lurasidone, its once-daily antipsychotic for the treatment of patients with schizophrenia. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/swiss_ok_for_takedas_schizophrenia_drug_lurasidone_1005544

24 Mar 2017:

UK Biobank attracts backing from GSK and Regeneron

GlaxoSmithKline and Regeneron have given their backing to a new project that will use patient data held by the UK Biobank. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/uk_biobank_attracts_backing_from_gsk_and_regeneron_1189980

23 Aug 2013:

Amgen rethinking offer price for Onyx?

Amgen is closing on a deal to acquire Onyx Pharmaceuticals after getting access to data on a key cancer drug , although reports suggest it is reining in the price it is prepared to pay. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/amgen_rethinking_offer_price_for_onyx_1005585

21 Aug 2013:

Bayer's Stivarga sets second OK in Japan

Bayer chalked up another approval for blockbuster-in-waiting Stivarga after Japan gave a green light for the drug's use in gastrointestinal stromal tumour (GIST). - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/bayers_stivarga_sets_second_ok_in_japan_1005571

4 Aug 2014:

PM Society digital award finalists announced

The shortlist is in – we now know who is up for one of this year’s PM Society Digital Media Awards. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/pm_society_digital_award_finalists_announced_1002285

19 Aug 2013:

Stada to buy OTC firm Thornton & Ross

German drugmaker Stada has finalised its acquisition of UK over-the-counter drugmaker Thornton & Ross in a deal valued at £221 million. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/stada_to_buy_otc_firm_thornton_and_ross_1005561

20 Mar 2013:

Trial aims to show Trajenta's role in diabetic kidney disease

Boehringer Ingelheim and Eli Lilly have started a Phase III trial designed to show their diabetes drug Trajenta is safe and effective in patients with signs of kidney damage. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/trial_aims_to_show_trajentas_role_in_diabetic_kidney_disease_1004674

29 May 2013:

AstraZeneca to pay $443m for Omthera Pharma

AstraZeneca will pay a maximum of $443 million for lipid lowering specialist Omthera Pharma to gain access to its anti-triglyceride drug Epanova. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/astrazeneca_to_pay_$443m_for_omthera_pharma_1005097

12 Feb 2013:

Treatment for alcoholism 'would save thousands'

Thousands of lives could be saved across the EU every year if therapy was used more frequently in alcohol-dependent patients, according to a new study. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/treatment_for_alcoholism_would_save_thousands_1004428